When you pay $1,349 per month for Wegovy, you're partly paying for the decade of clinical trials that established its safety and efficacy in studied populations, the FDA premarket review that verified those studies, the standardized manufacturing that guarantees dose consistency from vial to vial, and the ongoing pharmacovigilance that monitors real-world adverse events
"I think there's not enough research done on the contaminants in them." In a statement, the TGA said: "Unapproved peptides have not been assessed by the TGA for safety, quality or efficacy
The positive of the increase of these companies is the access, and its great that there are more avenues for patients to go, Pratt said
Nature 375 , 397400 (1995)
Nanoforming Biologics And GLP-1s: From I.V